Abnormal Heart Rate Regulation in GIRK4 Knockout Mice  by Wickman, Kevin et al.
Neuron, Vol. 20, 103±114, January, 1998, Copyright 1998 by Cell Press
Abnormal Heart Rate Regulation
in GIRK4 Knockout Mice
largely to respiratory sinus arrhythmia, a phenomenon
related to vagal tone withdrawal during inspiration (Saul
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Loewi et al. first demonstrated in 1926 that acetylcho-
line (ACh) secreted from the vagus nerve mediates theAcetylcholine (ACh) released from the stimulated va-
decrease in heart rate and contractility (Loewi and Nav-gus nerve decreases heart rate via modulation of sev-
ratil, 1926). After more than 70 years of research, how-eral types of ion channels expressed in cardiac pace-
ever, the identity of the relevant conductance(s) is stillmaker cells. Although the muscarinic-gated potassium
a matter of considerable debate. While early studieschannel IKACh has been implicated in vagally mediated indicated that vagal-mediated heart rate regulation washeart rate regulation, questions concerning the extent
due to ACh activation of a potassium-selective conduc-of its contribution have remained unanswered. To as-
tance termed IKACh (Giles and Noble, 1976; Noma andsess the role of IKACh in heart rate regulation in vivo, Trautwein, 1978; Garnier et al., 1978; Sakmann et al.,we generated a mouse line deficient in IKACh by targeted 1983), several lines of evidence suggest that vagal regu-disruption of the gene coding for GIRK4, one of the
lation of heart rate, particularly at low-to-moderate lev-channel subunits. We analyzed heart rate and heart
els of vagal activity, is due to changes in a cAMP-modu-
rate variability at rest and after pharmacological ma-
lated cationic conductance termed If , often referred tonipulation in unrestrained conscious mice using elec-
as the ªpacemakerº current (reviewed by DiFrancesco,
trocardiogram (ECG) telemetry. Wefound that IKACh me- 1995a). First, If in rabbit sinoatrial nodal cells was showndiated approximately half of the negative chronotropic to be potently inhibited by ACh (DiFrancesco and
effects of vagal stimulation and adenosine on heart Tromba, 1988). Second, concentrations of ACh too low
rate. In addition, this study indicates that IKACh is neces- to stimulate IKACh were shown to decrease the firing fre-sary for the fast fluctuations in heart rate responsible quency of isolated sinoatrial nodal cells, acting through
for beat-to-beat control of heart activity, both at rest adenylyl cyclase inhibition and a decrease in the If cur-and after vagal stimulation. Interestingly, noncholiner- rent (DiFrancesco et al., 1989). Third, the membrane
gic systems also appear to modulate heart activity conductance of pacemaker cells was shown to de-
through IKACh. Thus, IKACh is critical for effective heart crease in response to vagal stimulation or ACh super-
rate regulation in mice. fusion, as would be predicted if the dominant pacing
current was inhibited, rather than stimulated, by ACh
Introduction (Bywater et al., 1990; Hirst et al., 1992). In addition to IKACh
and If, L-type Ca21 channels and the sustained inward
The discharge frequency of the sinoatrial node, the dom- current (Ist) have been described in sinoatrial nodal cells
inant pacemaking center in the mammalian heart, is and implicated in mediating the autonomic regulation
modulated by the tone of the autonomic nervous sys- of cardiac pacing (Noma et al., 1983; Hagiwara et al.,
tem. The opposing effects of sympathetic and parasym- 1988; Guo et al., 1995). Unfortunately, the lack of selec-
pathetic activity generate beat-to-beat fluctuations in tive pharmacological agents for IKACh and other currents
heart rate, a phenomenon termed heart rate variability relevant to cardiac pacing has made dissection of the
(HRV; Akselrod et al., 1981; Saul and Cohen, 1994). Phar- relative contributions of these conductances in vivo im-
macological dissection of HRV in large mammals has possible.
revealed correspondence between different autonomic IKACh has been well characterized in terms of distribu-
inputs to the heart and particular frequency components tion in the heart, biophysical properties, and gating regu-
of HRV (Akselrod et al., 1981; Saul et al., 1991). For exam- lation (reviewed by Kurachi et al., 1992; Wickman and
ple, the 0.15±0.4 Hz component of HRV in humans is due Clapham, 1995). IKACh is present in the sinoatrial node,
atria, atrioventricular node, and possibly Purkinje fibers
of mammalian heart. The channel exhibits strong inward‖ These authors contributed equally to this work.
# To whom correspondence should be addressed. rectification, high potassium (K1) selectivity, a unitary
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conductance of z35 pS at physiological K1 concentra-
tions, and a 1±2 ms mean open time. While it is named
after the first identified agonist, IKACh is also activated
by a variety of neurotransmitters, including adenosine
(Hartzell, 1979). IKACh activation by adenosine may be
responsible for the profound transient bradycardia and
atrioventricular block seen in humans after administra-
tion of adenosine (DiMarcoet al., 1983; Clemo and Belar-
dinelli, 1986; Kurachi et al., 1986). The neurotransmitters
and hormones that activate IKACh all stimulate pertussis
toxin±sensitive G proteins, resulting in the dissociation
of the G protein complex into Gbg and GTP-bound Ga
subunits. Liberated Gbg activates IKACh directly by physi-
cal association (Huang et al., 1995; Inanobe et al., 1995;
Krapivinsky et al., 1995c).
Cardiac IKACh is comprised of two related proteins,
termed GIRK1 and GIRK4 (Dascal et al., 1993; Kubo et
al., 1993; Krapivinsky et al., 1995a). Functionally similar
G protein±gated K1 channels in brain and other tissues
are thought to be formed by various combinations of
GIRK family subunits (GIRK1, GIRK2, GIRK3, and GIRK4)
(Lesage et al., 1994; Duprat et al., 1995; Ferrer et al.,
1995; Kobayashi et al., 1995; Kofuji et al., 1995; Karschin
et al., 1996; Velimirovic et al., 1996). In heterologous
expression systems, both GIRK1 and GIRK4 are re-
quired to formthe functional IKACh channel; in the absence
of the GIRK4 subunit, GIRK1 does not form a functional Figure 1. Characterization of GIRK4-Deficient Mice
ion channel (Krapivinsky et al., 1995a, 1995b; Hedin et (A) GIRK4 targeting strategy. Schematic depiction of the mouse
GIRK4 wild-type and targeted alleles and targeting vector. Abbrevia-al., 1996). Therefore, we disrupted the mouse GIRK4
tions for restriction enzyme sites are as follows: Bg, BglII; B, BamHI;gene in an effort to determine the contribution of this
and H, HincII. ª(B)º and ª(Bg)º identify BamHI and BglII sites bluntedconductance to cardiac function and regulation. Here,
during vector construction. The directions of the neomycin (neor)
we report that GIRK4-deficient mice lack cardiac IKACh gene and diptheria toxin (DTA) gene transcription are indicated by
but are viable and exhibit no difference from wild-type arrowheads. ªExon1º and ªExon2º denote the first and second
siblings in terms of mean resting heart rate. Results from GIRK4 codingsequence exons, respectively, and ªATGºand ªSTOPº
indicate the locations of the translation initiation codon and stoppharmacological stimulation of the vagusand adenosine
codon, respectively. The gray box denotes the 39 flanking probeadministration in unrestrained conscious GIRK4-defi-
used for Southern analysis of ES cell and mouse tail DNA. Thecient mice indicate that IKACh accounts for z50% of the analogous HincII restriction fragments for the wild-type and targeted
negative chronotropic response to these perturbations. GIRK4 alleles are 9.5 and 8.9 kb, respectively.
In addition, unlike their wild-type siblings, GIRK4-defi- (B) Southern blot of tail DNA from six F2 littermates derived from
cient mice are unable to adjust heart rate on a rapid heterozygous parents (two mice representing each possible geno-
type: wild-type [WT], heterozygous [HT], and knockout [KO]). Tailtime scale (,2 s), even at rest. Thus, this study demon-
DNA samples (z5±10 mg) were digested with HincII restriction en-strates the pivotal role of IKACh in heart rate regulation
zyme and probed with the radiolabeled 39 flanking probe depictedover a substantial range of vagal activity.
in (A).
(C and D) Northern analysis of total atrial RNA. Ten to fifteen micro-
grams of total atrial RNA isolated from the mice genotyped in (B)
Results were loaded per lane. The same Northern blot was hybridized with
random-primed PCR-generated probes specific for GIRK4 (C) and
GIRK1 (D). The diffuse band visible below the 4.4 kb marker in (C)A 14 kb 129Sv/J mouse genomic DNA fragment (Wick-
corresponds to the location of the 28S ribosomal RNA band.man et al.,1997) containing two GIRK4 coding sequence
(E) Western blots of crude atrial membrane proteins from wild-typeexons was used to generate a gene targeting construct.
and knockout mice (two samples each). The blot was probed with a
The construct contained a neomycin resistance gene GIRK1 antibody (top), stripped, and reprobed with a GIRK4 antibody
(positive selection), a diptheria toxin gene (negative se- (bottom). The GIRK1 antibody recognizes both glycosylated (GIRK1-
lection), and z8 kb of overall GIRK4 homology (Figure gly) and unglycosylated (GIRK1-core) forms of GIRK1.
1A). The first GIRK4 coding sequence exon was targeted
because it codes for critical functional domains in
GIRK4, including the entire amino terminus, both mem- which transmitted the GIRK4 mutation to progeny. Pure
strain (129Sv/J) and mixed strain (129Sv/J 3 C57Bl6/J)brane-spanning domains, the predicted pore-lining se-
quence, and a large portion of the carboxyl terminus. crosses of heterozygous mice were established to gen-
erate mice homozygous for the GIRK4 mutation. ViableTwo of 480 screened transfected embryonic stem (ES)
cell clones exhibited a properly targeted GIRK4 allele GIRK4-deficient mice derived from both ES cell clones
were identified by Southern blotting and/or a PCR-(data not shown). Both clones were used to generate
chimeric mice, and both yielded male chimeric mice, based screen (Figure 1B). The genotype distribution
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Figure 2. Electrophysiological Analysis of Mouse Atrial Myocytes
(A) Single-channel recording from a wild-type atrial myocyte. With 10 mM ACh in the pipette, IKACh activity was observed in the cell-attached
configuration but declined after patch excision. Channel activity was restored upon addition of GTPgS to the bath. Recording artifacts due
to addition of GTPgS to the bath have been deleted. The asterisk indicates the recording segment expanded in the inset.
(B) Single-channel recording from a knockout atrial myocyte. No IKACh activity was observed in either the cell-attached or inside-out configuration
(n 5 49).
In both (A) and (B), holding potential was 280 mV with periodic voltage jumps to 80 mV to test the inward rectification of the observed
channels.
from heterozygous intercrosses was as follows: wild To test whether disrupting the GIRK4 gene eliminated
the function of cardiac IKACh, we patch clamped isolatedtype, 26%; heterozygous, 52%; and homozygous null,
22%; based on screening of 350 offspring. There was atrial myocytes from wild-type, heterozygous, and knock-
out mice. Characteristic IKACh activity was observed in 47no significant gender bias for inheritance of the targeted
allele (males, 49%; females, 51%). GIRK4-deficient mice of 50 patches from wild-type and heterozygous mice in
either the cell-attached or inside-out configuration. Theappeared normal by all visual criteria.
A Northern blot of total RNA isolated from atria from three cells from wild-type mice lacking observable IKACh
activity may have been fibroblasts, which comprise awild-type, heterozygous, and knockout siblings was
blotted sequentially with radiolabeled probes specific part of all cardiac cultures. The primary biophysical
characteristics of mouse cardiac IKACh were indistinguish-for GIRK4 (Figure 1C) and GIRK1 (Figure 1D), as well as
for GIRK2, GIRK3, and b-actin (data not shown). As able from previously described rat and guinea pig atrial
IKACh (Logothetis et al., 1987; Kurachi et al., 1992; Wick-expected, GIRK4 mRNA was absent in knockout mice
but present in wild-type and heterozygous mice. Inter- man et al., 1994); the single channel conductance (mea-
sured at 280 mV) was 31 6 1 pS (6SD), and the averageestingly, GIRK1 mRNA levels were constant across all
genotypes. No expression of GIRK2 or GIRK3 mRNA open time duration was 2.1 ms. The channel was acti-
vated by ACh in the cell-attached configuration and bywas detected by Northern blotting or RT-PCR (data not
shown) in atrial tissue for any of the genotypes, arguing GTPgS in the inside-out configuration (Figure 2A). No
IKACh activity was observed in patches from knockoutthat these functional GIRK4 homologs do not compen-
sate for the GIRK4 deficiency in heart. Lack of atrial mice (n 5 49; Figure 2B). Patch vesicle formation cannot
explain the lack of observed IKACh activity in knockoutGIRK4 protein in knockout mice was demonstrated by
Western blotting of atrial membrane proteins (Figure 1E, cardiomyocytes, as other cardiac potassium channels
were observed with characteristic frequencies (IKATP,bottom). Furthermore, knockout mouse atria contained
significantly decreased (4- to 8-fold) levels of GIRK1 30/49; IK1, 4/49). This finding proves that GIRK4 is re-
quired for IKACh formation, supports data suggesting thatprotein as ascertained by a carboxy-terminal±directed
GIRK1 antibody (Figure 1E, top). No discernable differ- GIRK1 alone is unable to form functional K1 channels
(Krapivinsky et al., 1995a, 1995b; Hedin et al., 1996),ence was detected in GIRK1 and GIRK4 protein levels
between heterozygous and wild-type mice. and argues that the functional homologs GIRK2 and/or
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Figure 3. ECG, HR Fluctuations, and Power
Spectra of GIRK4-Deficient Mice
(A) One-lead baseline ECG recorded simulta-
neously from wild-type, heterozygous, and
knockout mice.
(B) Comparison of beat-to-beat changes in
RR intervals (time interval between succes-
sive R peaks on an ECG) between wild-type
and knockout littermates at baseline. RR in-
tervals, the intervals between successive
heart beats (ventricular depolarizations), are
plotted against time (s). Note the spontane-
ous slowing of heart rate in the wild-type ani-
mal (bar).
(C) Power spectra of the RR signal (HRV spec-
tra) from a wild-type (left) and knockout (right)
mouse at rest. HRV in the LF (0.4±1.5 Hz)
range is nearly absent in the knockout animal.
(D) One-lead ECG from the same mice as in
(A), after methoxamine administration. Brady-
cardia is more pronounced in wild-type and
heterozygous mice.
(E) Comparison of beat-to-beat changes in
RR intervals between wild-type and knockout
mice after administration of methoxamine.
Note that the RR interval fluctuations in the
wild-type mouse contrast dramatically with
the steady heart rate of the knockout mouse.
(F) Power spectra of the RR signal from a
wild-type (left) and knockout (right) mouse
after methoxamine administration. Again,
HRV in the LF range is nearly absent in the
knockout mouse. Due to the large HRV in-
crease in the wild-type mouse, the y-axis was
contracted 25-fold.
GIRK3 did not compensate for the GIRK4 deficiency in steep ª1/f-typeº component in the VLF range. This 1/f-
type component is observed in all HRV spectra, includ-atrial tissue.
Given the absence of cardiac IKACh in GIRK4-deficient ing those of wild-type mice. In contrast to wild-type
mice, the HRV spectra of GIRK4-deficient mice had mini-atrial myocytes, we turned to analysis of heart function
in unrestrained conscious mice using electrocardiogram mal power in the LF range (0.00709 versus 0.0863 ms2/s,
respectively, p , 0.001; Figure 4A). Spectral power in(ECG) telemetry to determine the physiological signifi-
cance of this conductance. Surprisingly, resting mean the HF range was also significantly lower in knockout
mice (0.0319 versus 0.0780 ms2/s, p , 0.05), whereasheart rate did not differ between knockout and wild-
type mice (647.2 and 646.8 bpm, respectively). At rest, the VLF component of HRV did not differ between mice
of different genotypes.the most striking difference between wild-type and
knockout siblings was that wild-type mice often exhib- We tested a panel of pharmacological agents, which
selectively target signaling pathways relevant to heartited episodes of mild bradycardia with rapid onset last-
ing 5±10 s (Figures 3A and 3B). In contrast, the heart rate regulation. Methoxamine and CCPA (2-chloro, N6-
cyclopentyl adenosine) were used to test the effects ofrates of GIRK4-deficient mice did not change over time
scales shorter than z2 s, with the exception of fast GIRK4 ablation on vagal-mediated and vagus-indepen-
dent signaling pathways thought to culminate in IKACh(2±4 Hz) oscillations of low amplitude (1±2 ms). This is
reflected in the HRV spectra from wild-type and knock- activation. Methoxamine, an agonist of a1-adrenergic
receptors, induces bradycardia by causing vasocon-out mice (Figure 3C). Analogous to studies of HRV in
large mammals, the spectra were subdivided into three striction, leading to elevated blood pressure and an in-
crease in vagal activity through baroreflex stimulation.frequency ranges and adjusted 10-fold to account for
the faster murine heart rate: high frequency (HF, 1.5±5 Thus, methoxamine indirectly activates thecardiac mus-
carinic receptors relevant to vagal modulation of heartHz), low frequency (LF, 0.4±1.5 Hz) and very low fre-
quency (VLF, ,0.4 Hz) (Bigger et al., 1992). The HRV rate. Baroreflex stimulation is used in clinical practice
to assess vagal bradycardia (Eckberg et al., 1971; Farrelspectra of knockout mice consisted of two distinct com-
ponents: a small peak in the HF range (2±4 Hz) and a et al., 1991). We felt that methoxamine was preferable to
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Figure 5. HRV of Wild-Type and GIRK4-Deficient Mice after
Atropine
Atropine predominantly decreases the LF component of HRV, with
the larger decreaseobserved in wild-type mice (black bars). Interest-
ingly, knockout mice (white bars) still exhibited lower HRV in both
HF and LF ranges after atropine. Note that the logarithmic scale on
the left applies to the HRV indices, whereas the linear scale on
the right applies to heart rate. Error bars indicate 95% confidence
intervals, and the asterisk indicates the statistical significance of
the difference between wild-type and knockout mice (*p , 0.05).
longer lasting effects. Furthermore, adenosine adminis-
tration would be likely to stimulate A2 as well as A1 recep-
tors, leading to hypotension and secondary autonomic
changes (Conti et al., 1993).
Shortly after methoxamine administration (usually
within 2±3 min), wild-type mice developed bradycardia
(Figure 3D). While the heart rate of GIRK4-deficient mice
also decreased after methoxamine administration, the
effect was less than that observed in wild-type siblings
(564 6 30 versus 463 6 44 bpm, respectively, p , 0.01;
Figure 4B). Following methoxamine administration, wild-
type mice also exhibited a dramatic increase in HRV,
especially in the HF and LF ranges; the increase in HRV
Figure 4. HRV of GIRK4-Deficient Mice seen in wild-type mice was absent in their knockout
(A) Quantitative comparison of basal HRV and heart rate between littermates (Figure 3E). The LF component of HRV after
wild-type (black bars) and knockout mice (white bars). Note that the methoxamine administration was more than 1000-fold
logarithmic scale on the left applies to the HRV indices, whereas lower in knockout mice compared to their wild-type sib-
the linear scale on the right applies to heart rate. Although the mean lings (0.00362 versus 8.04 ms2/s, p , 0.01; Figure 4B).heart rate is the same in wild-type and knockout mice, LF and HF
Similarly, CCPA administration caused bradycardia incomponents of HRV are lower in knockout mice.
both wild-type and knockout mice, with the effect being(B) Comparison of HRV andheart rate between wild-type and knock-
out mice after methoxamine administration. In wild-type mice, heart more pronounced in wild-type mice (469 6 65 versus
rate is lower and HRV is higher in all frequency bands. 230 6 33 bpm, knockout versus wild type; p , 0.001).
(C) Comparison of HRV and heart rate between wild-type and knock- CCPA also led to a large increase in HRV in wild-type
out mice after CCPA adminstration. As with methoxamine, wild-type mice, particularly in the HF and LF ranges. After CCPA
mice have lower heart rate and higher HRV in all frequency bands.
administration, the LFcomponent of HRV was more thanFor all figures, the error bars indicate 95% confidence intervals,
1000-fold lower in knockout mice (0.0272 versus 59.7and symbols indicate the statistical significance of the difference
between wild-type and knockout mice (*p , 0.05, **p , 0.01, ²p , ms2/s, p , 0.001; Figure 4C).
0.001). Because adjustments in autonomic nervous system
output are the primary source of HRV, we tested the
effects of parasympathetic (atropine) and sympathetic
(propranolol) blockade on heart rate and HRV in wild-direct or indirect muscarinic agonists (ACh, carbachol,
bethanechol, organophosphates), since most of these type and GIRK4-deficient mice. Compared to saline in-
jection, atropine did not cause significant tachycardiasubstances applied to the whole animal would likely
elicit many noncardiac effects, including bronchial se- in wild-type (674 and 667 bpm, atropine versus saline)
or knockout (661versus 699 bpm, atropine versus saline)cretion, diarrhea, and hypotension, which would con-
found our interpretation. CCPA is thought to activate mice. However, the LF component of HRV was de-
creased after atropine administration compared to sa-IKACh via stimulation of sinoatrial nodal A1 adenosine re-
ceptors. CCPA is preferred in this application over aden- line injection in both wild-type (0.0255 versus 0.115
ms2/s, p , 0.02; Figure 5) and knockout mice (0.00641osine because it is a selective A1 receptor agonist, it
can be administered intraperitoneally, and it exhibits versus 0.0109 ms2/s, p , 0.01). Interestingly, atropine
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did not completely eliminate the difference between characteristics dissimilar to any previously reported na-
tive conductance (Krapivinsky et al., 1995a, 1995b).wild-type and knockout mice, since the differences in
both LF and HF components of HRV after atropine injec- Thus, we speculated that disruption of the mouse GIRK4
gene would effectively eliminate all cardiac G protein±tion are still significant (LF, 0.00641 versus 0.0255 ms2/s,
p , 0.02; HF, 0.0223 versus 0.0918 ms2/s, p , 0.05; gated atrial K1 conductance. Indeed, the absence of
IKACh activity in GIRK4-deficient atrial myocytes isolatedknockout versus wild type). Propranolol administration
caused bradycardia in both wild-type and knockout from mice derived from two independent targeted ES
cell clones is strong evidence that GIRK4 is required formice (data not shown); the effect on heart rate was
profound (z300 bpm decrease) in certain mice regard- IKACh formation. Furthermore, a preliminary attempt at
functional IKACh reconstitution in atrial myocytes isolatedless of genotype. HRV spectra of these mice were dis-
torted and shifted toward lower frequencies. However, from GIRK4-deficient mice by transfection of a rat GIRK4
cDNA was successful (data not shown). The lack ofsince the profound effects were observed only in certain
mice from both genotypes, the confidence intervals IKACh in GIRK4-deficient mice also indicates that GIRK4
functional homologs (GIRK2 and GIRK3) do not compen-were wide, and the difference in heart rate or HRV indi-
ces between wild-type and knockout mice after pro- sate for this deficiency in atrial tissue.
The level of GIRK1 mRNA was similar in wild-type,pranolol did not reach statistical significance.
Heart rate and HRV indices of heterozygous mice did heterozygous, and knockout mice, while GIRK1 protein
was significantly reduced in knockout mice. Interest-not differ significantly from that of wild-type mice after
atropine, propranolol, methoxamine, or CCPA. On pair- ingly, virtually no GIRK1 protein was detected using
antibodies directed against a short amino-terminal GIRK1wise comparison, the high frequency range of HRV at
baseline was higher for heterozygous than for wild-type sequence, which readily detect GIRK1 in wild-type atria
(data not shown). In contrast, a relatively modest de-mice. However, this result is not significant when
corrected for multiple comparisons by the Bonferroni crease (5-fold) in GIRK1 protein in knockout mice was
observed using a carboxy-terminal GIRK1 antibody.method; in contrast, the difference between wild-type
and knockout mice is highly significant after Bonferroni This observation suggests that amino-terminal proteoly-
sis of GIRK1 might occur to a greater extent in thecorrection (p , 0.001).
Since both vagal tone and adenosine have been impli- absence of GIRK4 and could explain the similar dramatic
decrease in GIRK1 protein observed in GIRK2 knockoutcated in the control of atrioventricular conduction prop-
erties (DiMarco et al., 1983; Clemo and Belardinelli, mice, also assessed using an amino-terminal±directed
GIRK1 antibody (Signorini et al., 1997). Regardless of1986; Kurachi et al., 1986), we measured the effects of
GIRK4 disruption on PR interval duration (time interval the mechanism, the GIRK2 and GIRK4 knockout studies
both suggest the existence of a posttranscriptionalbetween atrial and ventricular depolarization) at baseline
and after methoxamine administration. The small differ- mechanism for regulation of GIRK subunit levels.
Remarkably, resting heart rate in unrestrained con-ence in PR interval duration between wild-type and
GIRK4-deficient mice was of borderline statistical signif- scious wild-type and GIRK4 knockout mice was virtually
identical, indicating that other signaling pathways in-icance (32.1 6 2.6 versus 34.9 6 2.8 ms, knockout versus
wild type; p , 0.05). Since this difference disappeared volved in heart rate regulation can balance the missing
IKACh current. Other groups have reported no change inafter CCPA administration (37.7 6 4.1 versus 36.9 6 3.6
ms, knockout versus wild type), the importance of this heart rate in mice overexpressing a b-adrenergic recep-
tor kinase 1 (bARK1) inhibitor (Koch et al., 1995), G pro-finding is uncertain, but it appears that IKACh is not critical
for atrioventricular conduction properties in mice. Fur- tein±coupled receptor kinase 5 (GRK5; Rockman et al.,
1996), and the b1-adrenergic receptor (Bertin et al.,thermore, there was no obvious difference in the fre-
quency of ectopic beats between the wild-type and 1993), as well as in b1-adrenergic receptor knockout
mice (Rohrer et al., 1996). Thus, mean resting heart rateknockout mice. In .3 hr of analyzed baseline data, no
more than 10 ventricular ectopic beats were detected is determined by several redundant signaling pathways.
Elevated basal heart rate has been reported in mice within any mouse. Apart from one wild-type mouse with
frequent supraventricular ectopy (.200 ectopic beats cardiac overexpression of the b2-adrenergic receptor
(Milano et al., 1994) and Gas (Iwase et al., 1996), whereasover 3 hr), supraventricular ectopic beats were infre-
decreased heart rate was found in mice overexpressingquent in mice of all genotypes.
bARK1 (Koch et al., 1995) and in tyrosine hydroxylase
knockout mouse embryos (Zhou et al., 1995). However,
Discussion in some reports the heart rate was measured during
anesthesia or control infusion and may not reflect true
While the brain probably assembles G protein±gated K1 resting heart rate of the mouse.
channels from the entire repertoire of available GIRK We report a higher resting mean heart rate (650 bpm)
subunits (GIRK1, GIRK2, GIRK3, and GIRK4), cardiac for mice than other groups (450±550 bpm). However,
IKACh is comprised entirely of associated GIRK1 and many of these previous studies measured mean heart
GIRK4 subunits (Krapivinsky et al., 1995a). Experiments rate during general anesthesia (Bertin et al., 1993; Koch
in heterologous expression systems suggest that the et al., 1995; Iwase et al., 1996) or in tethered and cannu-
GIRK1 subunit is unable to form a functional channel lated mice (Rockman et al., 1996; Rohrer et al., 1996;
when expressed alone (Krapivinsky et al., 1995; Hedin Desai, 1997). It is conceivable that cannulation of the
et al., 1996). GIRK4 alone, in contrast, does form a G carotid artery could lead to baroreflex stimulation or that
the tethered animals were less active than unrestrainedprotein±gated K1 channel, albeit with single channel
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Figure 6. Mechanisms of Heart Rate Regu-
lation
A schematic compilation of heart rate regula-
tion data from mice, rabbits, and guinea pig
(DiFrancesco and Tortora, 1991; Hartzell et
al., 1991; Freeman and Kass, 1993; Huang
et al., 1994; Guo et al., 1995; Noma, 1996).
Sympathetic stimulation (norepinephrine) ini-
tiates a cAMP cascade, which directly modu-
lates the If conductance and indirectly modu-
lates the activity of several ion channels.
Parasympathetic stimulation (acetylcholine)
and adenosine counteract the modulatory
cAMP pathways via inhibition of adenylyl cy-
clase as well as directly stimulating IKACh. Ab-
breviations: NE, norepinephrine; b1-AR, type
1 b-adrenergic receptor; ACh, acetylcholine;
M2, type 2 muscarinic receptor; Ado, adeno-
sine; A1, type 1 adenosine receptor; PKA, pro-
tein kinase A; Gas, G protein a subunit (stimulates adenylyl cyclase); Gai, G protein a subunit (inhibits adenylyl cyclase); Gbg, G protein bg
subunit; If, pacemaker current; Ist, sustained inward current; IK, delayed rectifier potassium current; L-Ca21, L-type calcium channel; and IKACh,
muscarinic-gated atrial potassium channel.
mice. Alternatively, it is possible that the implanted difference between wild-type and GIRK4-deficient mice
is the decreased HRV in the latter. GIRK4 knockout micetransmitters constituted a significant stress for ourmice,
elevating heart rate relative to that of nonimplanted have much lower HRV at frequencies above 0.4 Hz. At
rest, wild-type mice exhibit occasional rapid-onset epi-mice. Other groups that have used implanted telemetry
devices have reported resting murine heart rates similar sodes of mild bradycardia that last a few seconds, pre-
sumably related to a transient increase in vagal activity.to those of our mice (Ishii et al., 1996; Johansson and
Thoren, 1997). One study found that on days 3 and 4 While a similar phenomenon has been described pre-
viously in rats (Carre et al., 1994), this is not observedafter implantation, resting heart rate was 600±650 bpm.
After 1 week, resting heart rate decreased to 500±550 in GIRK4-deficient mice. The heart rates of GIRK4-defi-
cient mice change little apart fromsmall-amplitude regu-bpm (Johansson and Thoren, 1997). Thus, surgery-
related stress or other implantation-related factors lar oscillations at 2±4 Hz frequency; when heart rate
does change, it occurs gradually over several seconds.could have persisted in our mice until day 4 when we
acquired the resting mean heart rate data, diminishing a The difference in HRV between wild-type and knockout
mice is dramatic after vagal stimulation with methoxa-real heart rate difference between wild-type and GIRK4-
deficient mice. mine. Methoxamine leads to a major increase in HRV in
wild-type but not GIRK4-deficient mice, especially in theThe diminished bradycardic response of the GIRK4
knockout mice to CCPA and methoxamine indicates that LF range. In experiments involving direct vagal stimula-
tion of open-chest dogs, the sinus node responds toIKACh is responsible for approximately half of the heart
rate decrease in response to parasympathetic stimula- vagal stimulation much more rapidly than it does to
stimulation of sympathetic fibers (Berger et al., 1989).tion and to adenosine administration in vivo. We suspect
that the residual bradycardic effects of CCPA and meth- The cellular response to vagal stimulation is likely to be
faster because it utilizes the faster membrane-delimitedoxamine in knockout mice are due to decreases in depo-
larizing current(s) (If , Ist, L-type voltage-gated Ca21 con- mechanism involving IKACh, whereas the sympathetic re-
sponse relies on slower changes in intracellular cAMPductance) directly or indirectly modulated by the cAMP
pathway (Figure 6). Theoretically, one could dissect the levels (Hartzell et al., 1991). The results from this study
are consistent with this proposition, because althoughresidual cAMP-relatedcardiac signalingpathways using
IKACh-deficient sinoatrial nodal cells and pharmacological GIRK4 knockout mice can still decrease their heart rate
in response toM2 and A1 receptor stimulation, their meantools such as PKA inhibitors in whole-cell experiments.
Atrial myocytes are probably not suitable for such as- resting heart rate changes more slowly than that of their
wild-type siblings.sessments since they may not contain the same set of
ion channels required for impulse generation and modu- In contrast toobservations in largemammals, atropine
did not cause tachycardia in wild-type mice. Atropinelation in sinoatrial nodal cells (DiFrancesco, 1995a,
1995b; Guo et al., 1995). Thus, the exact identities of the did decrease HRV, with the most pronounced effect
seen in the low frequency range. Both of these observa-residual cardiac pacing systems in the GIRK4 knockout
mice will require the rigorous electrophysiological char- tions in mice have been reported previously (Mansier et
al., 1996). Presumably, mice have lower resting vagalacterization of murine sinoatrial nodal cells.
HRV analysis was performed in addition to measure- tone than large mammals, with most of their vagally
mediated HRV concentrated in the LF (0.4±1.5 Hz) range.ment of heart rate, because changes in certain fre-
quency components of HRV can reveal abnormalities As expected, the decrease in the LF contribution to
HRV was larger in the wild-type animals. Surprisinglyin autonomic regulation of cardiac pacing that are not
necessarily reflected in changes inmean heart rate mea- however, GIRK4-deficient mice had lower HRV in both
LF and HF ranges even after atropine administration.sured over minutes or hours. Indeed, the most striking
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Given the high concentration of atropine administered, support of this hypothesis, it was recently demonstrated
that IKACh was not required for the negative chronotropicit isunlikely that this observation is due to the incomplete
or slow onset of vagal blockade. A plausible explanation response to carbachol or adenosine seen in cardiomyo-
cytes derived from ES cells lacking Ga i2 or Ga i3 (Sowellis that IKACh is regulated by receptors other than M2 and
that this activity persists in atropinized wild-type mice. et al., 1997). However, the observed difference in HRV
between unrestrained GIRK4-deficient mice and wild-Indeed, IKACh can be activated by adenosine, somato-
statin and calcitonin gene±related peptide as well as type littermates at rest argues that IKACh is important for
heart rate regulation even at baseline, when vagal toneacetylcholine (Hartzell, 1979; Lewis and Clapham, 1989;
Kim, 1991). Currently, however, there is no direct evi- is not elevated. The lack of substantial effect of atropine
on heart rate supports our contention that vagal tone indence that these substances regulate heart rate under
normal conditions. unrestrained wild-type mice is low relative to that of
large mammals. We suggest that the amount of AChThe exact origin of the 2±4 Hz oscillations of heart rate
in GIRK4-deficient mice is currently unknown. These released from the vagus at baseline is sufficient to mod-
ulate both IKACh and If and possibly other relevant conduc-oscillations are also observed in wild-type animals and
persist after atropine administration. Since they persist tances. Certainly, this study underscores the benefits of
an in vivo model for dissecting complex and convergentafter atropine administration in knockout mice, the oscil-
lations are probably not vagally mediated. We speculate signaling pathways.
In summary, we conclude that GIRK4 is indispensablethat they are caused by a direct mechanical stretch of
the sinus node caused by intrathoracic pressure changes for formation of cardiac IKACh, and that IKACh accounts for
approximately half of the bradycardia induced by vagalassociated with respiration. This mechanism has been
well documented for other mammals, accounting for stimulation and adenosine administration. Furthermore,
this study demonstrates that IKACh is necessary for fastresidual respiratory sinus arrhythmia after complete au-
tonomic blockade (Koizumi et al., 1975; Bernardi et al., regulation (,2 s) of the heart rate, both at rest and during
baroreflex stimulation; sudden changes in heart rate are1989; Saul and Cohen, 1994). Indeed, the frequency of
these oscillations (2±4 Hz) is consistent with the murine virtually absent in GIRK4-deficient mice. Finally, the ob-
servation that atropine failed to reduce the HRV of wild-respiratory rate.
GIRK4 is expressed almost exclusively in heart atria type mice to the level observed in GIRK4-deficient mice
suggests that in normal mice at rest, IKACh is also regu-and pancreas (Ashford et al., 1994; Ferrer et al., 1995;
Krapivinsky et al., 1995a). Heart atria is the ideal tissue lated by nonmuscarinic agonists. We conclude that IKACh
is a critical effector of the parasympathetic branch offor studying the role of a G protein±gated K1 channel
in vivo, since the atrial G protein±gated K1 channel (IKACh) the heart rate regulatory system in mice.
is comprised exclusively of GIRK1 and GIRK4. In pan-
Experimental Procedurescreas, the GIRK4 functional homolog GIRK2 is also ex-
pressed. Based on results from in situ hybridization,
Generation of Targeted ES Cellsimmunohistochemistry, and cloning approaches, GIRK4
Cloning and mapping of the 129Sv/J mouse genomic DNA fragment
exhibits a highly restricted expression pattern in brain containing the two GIRK4 coding sequence exons were described
(Karschin et al., 1994, 1996; Iizuka et al., 1997; Murer et previously (Wickman et al., 1997). We replaced a z2.7 kb fragment
containing coding sequence exon 1 with the neomycin phospho-al., 1997). Furthermore, brain regions thought to express
transferase gene (neor) under the control of the mouse PGK pro-GIRK4 also express the functional homologs GIRK2 and
moter. The diptheria toxin gene (DTA) driven by the thymidine kinaseGIRK3. The potential functional compensation provided
promoter was included in the targeting vector to enrich for homolo-by these homologs will probably result in more subtle
gous recombinants. 129Sv/J ES cells (passage 10) were transfected
phenotypes with respect to brain and pancreas function with the linearized GIRK4 targeting vector as described (Spicer et
in the GIRK4-deficient mice. As was the case in heart, al., 1995), and 480 colonies surviving G418 selection (400 mg/ml
active constituent, 10 days) were picked and screened by PCR andpreliminary histology of pancreas and brain revealed
Southern blotting for homologous recombinants (targeting fre-no gross morphological differences associated with the
quency 5 2/480). Germline-transmitting chimeric mice were gener-GIRK4 deficiency. Studies are currently underway to
ated from both properly targeted ES cell clones.reveal any functional consequences of the GIRK4 abla-
tion in these tissues. Generation of GIRK4 Knockout Mice
The differences observed between wild-type and C57Bl6/J blastocysts were isolated on day 3.5 and injected with
GIRK4-deficient mice with respect to cardiac function eight to twenty ES cells. Eight to ten injected blastocysts were
transferred to each uterine horn of pseudopregnant recipient fe-at rest and after pharmacological manipulation argue
males (CD1 strain) at 2.5 days post coitum. Chimeric mice werestrongly that IKACh is involved in heart rate regulation in
identified on the basis of agouti/chinchilla pigmentation in the coat.mice over a substantial range of vagal activity. This
Male chimeric mice were crossed with both C57Bl6/J and 129Sv/J
conclusion contrasts somewhat with the model pro- females to screen for germline transmission of the targeted GIRK4
posed by DiFrancesco et al. (1989), which is based allele and to maintain the targeted mutation on inbred (129Sv) and
largely on electrophysiological data from isolated sinus outbred (C57Bl6/129Sv) genetic backgrounds. All mice were geno-
typed by Southern blotting or by PCR screening using tail DNAnodal cells. This group reported that ACh applied to
prepared as described (Spicer et al., 1995). For electrophysiologicalcanine sinoatrial nodal cells at concentrations too low
experiments on atrial myocytes, F2 siblings of appropriate genotypeto elicit IKACh activity did produce a negative chronotropic were mated to produce pups homozygous for either the null or wild-
response, presumably mediated by inhibition of the type GIRK4 allele. For the telemetry experiments, three same-sex
cAMP-dependent pacemaker current If. The authors F2 generation littermates, one representing each genotype (1/1,
suggested that IKACh does not play a role in heart rate 1/2, 2/2), comprised a study group and were implanted and moni-
tored simultaneously as described below. All implanted mice wereregulation at low-to-moderate levels of vagal activity. In
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5±7 months old and weighed at least 22 g. In total, ECG monitoring Mannheim) was added to the bath to a final concentration of 20
mM. The holding potential was 280 mV. Currents were recordedwas performed on seven study groups (four female, three male). Six
groups were derived from the same targeted ES cell clone. To con- with an Axopatch 200A amplifier (Axon Instruments) and stored on
videotape after 5 kHz filtering (4-pole low-pass Bessel). The signalfirm the specificity of the gene targeting event, a seventh group
derived from a different ES cell clone was tested. Both outbred was sampled digitally at 50 kHz and stored on computer hard disk
using pCLAMP6 (Axon Instruments) software. Although no further(C57Bl6/J 3 129Sv/J, three groups) and inbred (129Sv/J, four
groups) triplets were analyzed. No gender or strain-associated dif- filtering was performed on data used for quantitative analysis, data
displayed in figures were low-pass filtered at 2 kHz with an 8-poleferences were detected.
Butterworth filter prior to digitization. To estimate single channel
conductances and mean open times, idealized traces were createdNorthern Blotting
from 30 s data segments in the inside-out configuration in 10 patchesTotal atrial RNA was isolated from six littermates using TRIzol (Gib-
(ªdead time,º 200 ms). Single channel amplitude was fitted with acoBRL) according to the manufacturer's specifications. Probes
Gaussian curve using the pCLAMP6 software. The arithmetic aver-(300±500 bp) specific for GIRK1±4 wereprepared by PCR. The GIRK2
age of open time durations was computed using software writtenfragment was designed to recognize all reported alternatively
in TurboPascal v 7.0 (Borland International).spliced versions of GIRK2 (Isomoto et al., 1996). Fifteen micrograms
of total RNA was loaded per lane, in a 1% GTG agarose gel made
in 13 MOPS buffer. The gel was run at 5 V/cm for 5 hr and rinsed Telemetry
for 30 min in diethyl pyrocarbonate±treated (DEPC-treated) H2O to Implantable PhysioTel TA10EA-F20 radiotransmitters (Data Sci-
remove formaldehyde. RNA was capillary transferred to Hybond N1 ences International) were used for the ECG telemetry monitoring.
nylon membranes using 103 SSC. The blot was then rinsed for 5 Transmitters were implanted under the skin of the back under pento-
min in 53 SSC, followed by 2 hr baking at 808C. The blot was stained barbital anesthesia (30±50 mg/kg i.p.) and fixed to the back muscles
for 1 min in an 0.3 M Na acetate/0.03% methylene blue solution to with Prolene 5-0 sutures. The ECG leads were tunneled under the
assess the quality and quantity of the RNA. The blot was probed skin to the ventral aspect of the thorax and sutured to the thoracic
as described (Wickman et al., 1997). The blot was exposed to Bio- muscles in lead II position. Prolene 5-0 was also used to close the
Max MR X-ray film for 1±5 days. The order of probing and corre- incisions. After implantation (day 1), mice were allowed to recover.
sponding exposure times was as follows: GIRK4, 3 days; GIRK1, 3 Twenty-four hours of baseline ECG recording began on the morning
days; GIRK2, 5 days; GIRK3, 5 days; and b-actin, 1 day. of day 4 (10 to 12 a.m.). On day 5, animals were injected i.p. with
an 0.9% saline solution (20 ml/kg) as a vehicle control, followed by
at least 135 min with atropine sulphate (1 mg/kg; Fluka Chemical).Western Blotting
After a minimum of 6 hr, propranolol was administered (20 mg/kg;Crude atrial membrane proteins were prepared from dissected atrial
Fluka Chemical). On day 6, mice were injected i.p. with DMSO (3tissue pooled from three mice (6±8 weeks old) using a protocol
ml/kg of 0.1% solution in saline) as a vehicle control. After at leastmodified slightly from Jones et al. (1979). Briefly, samples were
135 min, mice were injected i.p. with methoxamine (6 mg/kg; RBI). Atthawed in 5 ml ice-cold buffer containing 100 mM NaCl, 20 mM
least 6 hr later, CCPA (2-chloro, N6-cyclopentyl adenosine; Sigma), aimidazole (pH 7.5), and 1 mM dithiothreitol (DTT). The tissue was
selective long-acting adenonsine A1 receptor agonist, was injectedhomogenized by polytron on ice using three 30 s pulses. After cen-
i.p. (0.3 mg/kg in 0.1% DMSO). ECGs were recorded for 15 mintrifugation at 1000 3 g for 10 min at 48C, KCl was added to a final
before and after each injection. Animals were sacrificed by etherconcentration of 700 mM to solubilize contractile elements, and the
inhalation, and transmitters were explanted and reused after clean-samples were rotated for 30 min at 48C. Membranes were pelleted
ing and sterilization with 2% glutaraldehyde.by ultracentrifugation at 50,000 rpm for 30 min using a Beckman
Sv-55 rotor. The pellet was resuspended by vigorous pipetting and
incubated for 1 hr on ice in a buffer containing 100 mM NaCl, 20 HRV Analysis
mM HEPES (pH 7.5), 1 mM EDTA, 1 mM DTT, and 1% CHAPS. The analog signal from the Data Sciences International receiver was
Insoluble elements were pelleted by centrifugation at 10,000 3 g digitized with 12-bit precision using a Digidata 1200B board (Axon
for 30 min at 48C. Soluble proteins were precipitated using 10% Instruments) using Axoscope software (Axon Instruments). Sam-
(v/v) trichloroacetic acid. Pellets were washed twice with 500 ml H2O, pling frequency was 2 kHz for the 24 hr recordings and 5 kHz for
resuspended in 20 ml of SDS loading buffer, and electrophoresed in the pharmacologic experiments. Custom-made software was used
an 11.5% polyacrylamide gel. Blots were probed with either affinity- to detect the R peaks of the ECG signal and to calculate the RR
purified GIRK1 (aCsh, 2 mg/ml; Krapivinsky et al., 1995a) or GIRK4 intervals. Mislabeled R peaks were corrected and noisy data seg-
(aCIRN2, 5 mg/ml; Krapivinsky et al., 1995a) antisera, as described. ments were replaced manually with a linear spline. Resulting RR
Proteins were visualized using the enhanced chemiluminescence data was interpolated linearly at 50 ms intervals to create equidistant
system (ECL, Amersham Life Science) according to the manufactur- points suitable for Fast Fourier Transform (FFT). Three epochs last-
er's protocols. ing 1 hr each were analyzed from each 24 hr recording (4 to 5 p.m.,
midnight to 1 a.m., and 8 to 9 a.m.). All 1 hr epochs and 15 min drug
recordings were divided into 204.8 ssegments, overlapping by 102.4Electrophysiology
Atrial auricles from neonatal mice (postnatal days 2±7) were micro- s. After linear detrending and windowing (3-term Blackman-Harris
window [Harris, 1978]), FFT was performed. Mean heart rate anddissected from total heart tissue. Isolated cardiomyocytes were pre-
pared using one of two protocols, the first modified slightly from HRV in HF (1.5±5.0 Hz), LF (0.4±1.5 Hz), and VLF (0.015±0.4 Hz)
ranges were computed from each data segment and normalized forDavies et al. (1996). Briefly, atrial tissue was digested using two 15
min incubations in buffer containing pancreatin (2.5 mg/ml) and segment duration. Cutoff frequencies for the HF, LF, and VLF bands
were based on those used in human studies multiplied by a factorcollagenase type I (0.5 mg/ml) at 378C. Dispersed cells were plated
onto fibronectin-coated glass coverslips in DMEM supplemented of 10 (the approximate ratio between murine and human HR [Bigger
et al., 1992]). Baseline segments with .10 s of splined data werewith 10% horse serum and 5% fetal bovine serum, and cultured in
10% CO2 at 378C for 2 days. Myocytes were also isolated using a excluded from analysis. Mean values of heart rate (arithmetic) and
HRV indices (geometric) were computed from 102 analyzed baselinemyocyte isolation kit according to the manufacturer's specifications
(Worthington). Electrophysiological experiments were performed data segments and from the seven data segments comprising the
15 min of data before and after each injection. Data from three micewithin 48 hr after plating. Pipettes for single-channel recording were
pulled from KG-12 glass (Garner Glass) using a P-97 Flaming/Brown (two 1/1, one 1/2) exhibiting intermittent rhythm disturbances (in-
termittent A-V block or intermittent junctional rhythm) were excludedpuller (Sutter Instrument), coated with HIPEC R-6101 Sylgard (Dow
Corning), and fire polished. Pipette resistance was 2±5 MV when from analysis. All other animals exhibited sinus rhythm. In all but
the first study group, the investigatorperforming the ECG monitoringfilled with K-5 solution (in mM): 118.5 KCl, 5 KOH/EGTA, 2 MgCl2,
and 10 KOH/HEPES (pH 7.2). Cell-attached and inside-out re- and HRV analysis was blinded to the mouse genotype. Paired t test
(littermates from the same group were paired) was used to comparecordings were performed with K-5 in the bath and K-5 plus 10 mM
ACh (Sigma) in the pipette. After patch excision, GTPgS (Boehringer the heart rate and logarithms of the HRV indices of the wild-type
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and knockout mice. Fifty PR intervals were measured manually from and with exercise: new tools to study models of cardiac disease.
Am. J. Physiol. 272, H1053±H1061.a baseline recording acquired at 5 kHz, and the arithmetic mean
was calculated for each animal and genotype. Heart rate and HRV DiFrancesco, D. (1995a). Cardiac pacemaker: 15 years of ªnewº
of heterozygous mice did not differ significantly from wild-type sib- interpretation. Acta Cardiol. 50, 414±427.
lings. Values of p , 0.05 were considered statistically significant. DiFrancesco, D. (1995b). The onset and autonomic regulation of
The Bonferroni method was used to correct for multiple compari- cardiac pacemaker activity: relevance of the f current. Cardiovasc.
sons when differences between the whole groups (wild type versus Res. 29, 449±456.
knockout and wild type versus heterozygote) were evaluated.
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